# Lamoille Health Partners, Inc.

Health Center, VT
Page: https://astrelis.co/providers/health_center/471820  
This twin: https://astrelis.co/providers/health_center/471820.md  
CMS Certification Number (CCN): 471820  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 15,984. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -54.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 5. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 8.8%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $14.7M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +16.7%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### LAMOILLE HEALTH PARTNERS INC, VT

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state (FACLAND tier 1)).

- FY ending 2025-09-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-09-GSAFAC-0000425742
- FY ending 2024-09-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-09-GSAFAC-0000372818
- FY ending 2023-09-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-09-GSAFAC-0000022095

| Line | FY ending 2025-09-30 | FY ending 2024-09-30 | FY ending 2023-09-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | absent (not printed, or not read) | 173,553 [derived, p.6] | 780,533 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 1,351,473 [derived, p.6] | 1,517,930 [derived, p.6] | 1,144,151 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 1,053,771 [derived, p.6] | 437,979 [derived, p.6] | 447,270 [derived, p.6] |
| other current assets (Statement of financial position) | 439,152 [derived, p.6] | 484,358 [derived, p.6] | 445,158 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 2,844,396 [extracted, p.6] | 2,613,820 [extracted, p.6] | 2,817,112 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 6,281,256 [derived, p.6] | 7,590,908 [derived, p.6] | 7,531,004 [derived, p.6] |
| other long-term assets (Statement of financial position) | 488,802 [derived, p.6] | 916,807 [derived, p.6] | 946,475 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 9,614,454 [extracted, p.6] | 11,121,535 [extracted, p.6] | 11,294,591 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 2,516,137 [derived, p.7] | 3,510,651 [derived, p.7] | 2,232,257 [derived, p.7] |
| deferred revenue (Statement of financial position) | 388,513 [derived, p.7] | 367,031 [derived, p.7] | 5,183 [derived, p.7] |
| current debt and leases (Statement of financial position) | 362,693 [derived, p.7] | 1,048,540 [derived, p.7] | 603,341 [derived, p.7] |
| other current liabilities (Statement of financial position) | 110,524 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 3,377,867 [extracted, p.7] | 4,926,222 [extracted, p.7] | 2,840,781 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | 3,511,735 [derived, p.7] | 4,674,002 [derived, p.7] | 5,200,664 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | 150,010 [derived, p.7] | 250,006 [derived, p.7] | 350,002 [derived, p.7] |
| TOTAL LIABILITIES (Statement of financial position) | 7,039,612 [extracted, p.7] | 9,850,230 [extracted, p.7] | 8,391,447 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 2,324,029 [derived, p.7] | 1,271,305 [derived, p.7] | 2,595,464 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | 250,813 [derived, p.7] | absent (not printed, or not read) | 307,680 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | 2,574,842 [extracted, p.7] | 1,271,305 [extracted, p.7] | 2,903,144 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 13,897,618 [derived, p.8] | 14,184,446 [derived, p.8] | 11,770,028 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | 5,672,260 [derived, p.8] | 4,496,237 [derived, p.8] | 2,469,706 [derived, p.8] |
| federal grants (Statement of activities) | 1,939,052 [derived, p.8] | 2,611,801 [derived, p.8] | 3,111,323 [derived, p.8] |
| other grants and contracts (Statement of activities) | 2,181,935 [derived, p.8] | 2,261,368 [derived, p.8] | 2,458,405 [derived, p.8] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 371,440 [derived, p.8] | 258,035 [derived, p.8] | 175,014 [derived, p.8] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 24,062,305 [extracted, p.8] | 23,811,887 [extracted, p.8] | 19,984,476 [extracted, p.8] |
| salaries and benefits (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | 4,536,678 [derived, p.8] | 3,367,094 [derived, p.8] | 1,889,423 [derived, p.8] |
| purchased and professional services (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 20,020,301 [derived, p.8] | 22,689,662 [derived, p.8] | 20,451,757 [derived, p.8] |
| TOTAL EXPENSES (Statement of activities) | 24,556,979 [extracted, p.8] | 26,056,756 [extracted, p.8] | 22,341,180 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | -494,674 [extracted, p.8] | -2,244,869 [extracted, p.8] | -2,356,704 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | 1,798,211 [derived, p.8] | 613,030 [derived, p.8] | 981,423 [derived, p.8] |
| CHANGE IN NET ASSETS (Statement of activities) | 1,303,537 [extracted, p.8] | -1,631,839 [extracted, p.8] | -1,375,281 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 1,271,305 [extracted, p.8] | 2,903,144 [extracted, p.8] | 4,278,425 [extracted, p.8] |
| net assets, end (Statement of activities) | 2,574,842 [extracted, p.8] | 1,271,305 [extracted, p.8] | 2,903,144 [extracted, p.8] |

| Ratio | FY ending 2025-09-30 | FY ending 2024-09-30 | FY ending 2023-09-30 |
|---|---:|---:|---:|
| Days cash on hand | absent [not computed] | absent [not computed] | absent [not computed] |
| Current ratio | 0.84x [plausible] | 0.53x [plausible] | 0.99x [plausible] |
| Operating margin | -2.1% [plausible] | -9.4% [plausible] | -11.8% [plausible] |
| Total margin | 5.4% [plausible] | -6.9% [plausible] | -6.9% [plausible] |
| Patient revenue share | 57.8% [plausible] | 59.6% [plausible] | 58.9% [plausible] |
| Grant dependency | 17.1% [plausible] | 20.5% [plausible] | 27.9% [plausible] |
| Salaries share | absent [not computed] | absent [not computed] | absent [not computed] |
| Days in patient receivables | 35 days [plausible] | 39 days [plausible] | 35 days [plausible] |
| Debt to net assets | 1.50x [plausible] | 4.50x [plausible] | 2.00x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (LAMOILLE HEALTH PARTNERS INC; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Lamoille Health Partners, Inc.", https://astrelis.co/providers/health_center/471820, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.